CHERYL ELDER: Open Payments
NPI 1033725353 · OWENSBORO, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,467 in 61 payments from 11 companies in 2025. Trend: 2023 $684 · 2024 $446 · 2025 $1,467
Food & beverage: $1,467
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $251 |
| ABBVIE INC. | 13 | $243 |
| Teva Pharmaceuticals USA, Inc. | 11 | $198 |
| E.R. Squibb & Sons, L.L.C. | 14 | $180 |
| Otsuka America Pharmaceutical, Inc. | 3 | $143 |
| Alkermes, Inc. | 2 | $143 |
| MDD US Operations, LLC | 1 | $118 |
| Vanda Pharmaceuticals Inc. | 4 | $75 |
| Neurocrine BioSciences, Inc. | 2 | $54 |
| Janssen Pharmaceuticals, Inc | 2 | $50 |
Products named: CAPLYTA, VRAYLAR, AUSTEDO XR, COBENFY, Qelbree, LYBALVI, REXULTI, FANAPT.
Industry payments across KY — which companies pay providers there.
